Navigating the Brain Cancer Maze with Professor Rajiv Khanna

Podcast: Play in new window | Download (Duration: 48:34 — 44.5MB) | Embed

Subscribe: Apple Podcasts | Google Podcasts | RSS

Promising Results From World-First Brain Cancer Trials

Professor Rajiv Khanna a leading researcher at The QIMR Berghofer Medical Research Institute, Brisbane, Australia; a world progressive translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Professor Khanna has been researching immunotherapies & has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). Professor Khanna developed a technique to modify the patients? T-cells in the laboratory, effectively ?train? them to attack the virus, and then return them to the patient?s body. When the killer T-cells destroyed the virus, they also destroyed the cancer. ?It?s becoming increasingly clear that immunotherapy – manipulating a person?s own immune system ? is a rich new frontier for cancer treatment,? Professor Khanna said. Be informed about the answer to cancer. Support Immunotherapy week. More info www.qimrberghofer.edu.au & gracegawlermedia.com

Prof Rajiv Khanna – Prof Rajiv Khanna obtained his doctorate degree from India & undertook his post-doctoral training at the University of Adelaide & (QIMR), Brisbane Australia. At QIMR Berghofer Medical Research Institute, Prof Khanna has been researching immunotherapy & has had a major breakthrough in treating the aggressive brain cancer, Glioblastoma Multiforme (GBM). He also holds a Senior Principal Research Fellowship from NH&MRC Australia. His research group have obtained a deeper understanding of the mechanisms by which an immune response to human herpes viruses associated diseases may be generated, augmented and applied to control these diseases. Prof. Khanna has developed novel immune-based therapeutic strategies for the treatment of patients with herpesvirus-associated complications & is lead investigator on five clinical trials. He has published more than 150 scientific papers in leading journals & holds numerous international patents on EBV and human cytomegalovirus. www.qimrberghofer.edu.au

Return to Home – for more uplifting Cancer Podcasts – Grace Gawler & Guests